Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR6 | P51684 | 3/20 | 0.60 |
| ▸ | CCR7 | P32248 | 1/20 | 0.60 |
| ▸ | CXCR2 | P25025 | 19/20 | 0.46 |
| ▸ | CXCR1 | P25024 | 13/20 | 0.46 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.38 |
| ▸ | CCR4 | P51679 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31114657 | 0.90 | CCR6 (0.72) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114815 | 0.88 | CCR6 (0.63) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114685 | 0.88 | CCR6 (0.54) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114817 | 0.85 | CCR6 (0.71) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114718 | 0.83 | CCR6 (0.69) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114660 | 0.83 | CCR6 (0.55) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114753 | 0.83 | CCR6 (0.74) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114715 | 0.82 | CCR6 (0.67) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114831 | 0.82 | CCR6 (0.60) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114710 | 0.81 | CCR6 (0.72) | CCR6CCR7CXCR2CXCR1CXCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4703354-A1 | COMPOUND AS CCR6 ANTAGONIST, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | Wuhan Createrna Science and Technology Co.,Ltd. (CN) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024222865-A1 | COMPOUND AS CCR6 ANTAGONIST, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 武汉朗来科技发展有限公司 | 2024-10-31 | — | — | WO | disclosed |